Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_assertion type Assertion NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_head.
- NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_assertion description "[ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_provenance.
- NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_assertion evidence source_evidence_literature NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_provenance.
- NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_assertion SIO_000772 15867198 NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_provenance.
- NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_assertion wasDerivedFrom befree-20140225 NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_provenance.
- NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_assertion wasGeneratedBy ECO_0000203 NP549655.RA14MpcvFTUS-dzDItkY7zDEw1AmDL3J2uBuiMyMod5LA130_provenance.